Plus Therapeutics Inc
Keeping an Eye on Plus Therapeutics Inc (PSTV) After Insider Trading Activity
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
The Potential Rise in the Price of Plus Therapeutics Inc (PSTV) following insiders activity
Plus Therapeutics Inc’s recently made public that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Plus Therapeutics Inc’s latest rating changes from various analysts
Plus Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Keeping an Eye on Plus Therapeutics Inc (PSTV) After Insider Trading Activity
Plus Therapeutics Inc’s recently made public that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Plus Therapeutics Inc [PSTV] Investment Guide: What You Need to Know
Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22 ...
Plus Therapeutics Inc (PSTV) receives a Buy rating from D. Boral Capital
Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22 ...
